Aptevo Therapeutics Inc (APVO)
4.84
+0.13
(+2.76%)
USD |
NASDAQ |
Dec 24, 16:00
Aptevo Therapeutics Free Cash Flow: -23.28M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Trevi Therapeutics Inc | -35.12M |
| Keros Therapeutics Inc | -142.50M |
| Johnson & Johnson | 19.02B |
| Eyenovia Inc | -30.64M |
| Applied Therapeutics Inc | -81.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.222M |
| Cash from Financing (Quarterly) | 4.909M |
| Free Cash Flow Per Share (Quarterly) | -18.32 |
| Free Cash Flow Yield | -6.05K% |